跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-BRIMONIDINE-TIMOP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
APO-BRIMONIDINE-TIMOP
Authorized
STANDARD
APO-BRIMONIDINE-TIMOP
Apotex Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a3115f29d5ce5602
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
a3115f29d5ce5602
Drug Approval Canada Name
APO-BRIMONIDINE-TIMOP
Product Name
APO-BRIMONIDINE-TIMOP
Status
Marketed
Status Date
2022-11-09
Original Market Date
2022-11-09
Din
02375311
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:40.04
Atc Original
S01ED51 TIMOLOL, COMBINATIONS
Atc Name
s 01 ed 51
Aig Number
0249643001
Company Name
Apotex Inc
Company Address
150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Active Ingredients
BRIMONIDINE TARTRATE
0.2 %
TIMOLOL (TIMOLOL MALEATE)
0.5 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a3115f29d5ce5602
Type
Standard
Back to Health Canada Approvals